Assessment of Effectivity of the Four Different Risk of Malignancy Indices (RMI 1-4) in the Differential Diagnosis of Endometrioma and Mature Cystic Teratoma

2013 ◽  
Vol 5 (3) ◽  
pp. 118-124
Author(s):  
Ali Yavuzcan ◽  
Mete Caglar ◽  
Yusuf Ustun ◽  
Serdar Dilbaz ◽  
Ismail Ozdemir ◽  
...  
Keyword(s):  
Differential Diagnosis ◽  
Cystic Teratoma ◽  
Mature Cystic Teratoma ◽  
Risk Of Malignancy

scholarly journals Antenatally Diagnosed Suprarenal Cystic Teratoma

2015 ◽  
Vol 7 (2) ◽  
pp. 44-46
Author(s):  
Sandeep Agarwala ◽  
Manisha Jana ◽  
MK Singh ◽  
Rajan Garg ◽  
Ankur Mandelia ◽  
...  
Keyword(s):  
Differential Diagnosis ◽  
Antenatal Diagnosis ◽  
Cystic Teratoma ◽  
Female Child ◽  
Cystic Mass ◽  
Histological Diagnosis ◽  
Mature Cystic Teratoma ◽  
Suprarenal Mass

ABSTRACT A two months old female child presented to us with an antenatal diagnosis of left suprarenal mass. Laparotomy revealed a large cystic mass in the left suprarenal location which was completely excised. The histological diagnosis was a mature, cystic teratoma. Although, the diagnosis of adrenal teratoma is rare, it should be considered in the differential diagnosis of antenatally diagnosed suprarenal lesions. How to cite this article Garg R, Mandelia A, Agarwala S, Bhatnagar V, Singh MK, Jana M. Antenatally Diagnosed Suprarenal Cystic Teratoma. World J Endoc Surg 2015;7(2):44-46.

scholarly journals Ovarian mature cystic teratoma with malignant transformation: two case reports

2021 ◽  
Vol 15 (1) ◽  
Author(s):  
Afsaneh Tehranian ◽  
Akram Ghahghaei-Nezamabadi ◽  
Akram Seifollahi ◽  
Sara Kasraei ◽  
Hamideh Dehghani-Nejad ◽  
...  
Keyword(s):  
Malignant Transformation ◽  
Case Reports ◽  
Cystic Teratoma ◽  
Good Prognosis ◽  
Mature Cystic Teratoma ◽  
Treatment Protocols ◽  
Large Size ◽  
Stage Ia ◽  
Loss Of Appetite ◽  
Case Number

Abstract Background Mature Cystic Teratoma (MCT) is a benign tumor that can lead to malignant transformation (MT) in 1–3% of cases. Management of MT is a big challenge for gynecologic oncologists due to the lack of specific diagnostic and treatment protocols. Case presentation We reported two Iranian cases of MT of MCT with two different stages and prognosis. Our both cases presented the same symptoms, including chronic abdominal pain and distention, loss of appetite, and weight loss. In case number 1, despite the large size of the tumor, the disease was at stage Ia and had a good prognosis; while, case number 2 was at stage IIIc of the disease with a poor prognosis. Conclusion The stage of the disease is the most important prognostic factor, and early diagnosis and treatment are very critical for better survival.

scholarly journals Genetic Profiling of Malignant Melanoma Arising from an Ovarian Mature Cystic Teratoma: A Case Report

2021 ◽  
Vol 22 (5) ◽  
pp. 2436
Author(s):  
Kohei Nakamura ◽  
Eriko Aimono ◽  
Reika Takamatsu ◽  
Shigeki Tanishima ◽  
Tomonari Tohyama ◽  
...  
Keyword(s):  
Malignant Melanoma ◽  
Malignant Tumors ◽  
Cystic Teratoma ◽  
Homozygous Deletion ◽  
Mature Cystic Teratoma ◽  
Genetic Profiling ◽  
Improve Treatment ◽  
The Status ◽  
Genetic Mechanisms ◽  
Targeted Gene Sequencing

Ovarian mature cystic teratomas comprise tissues derived from all three germ layers. In rare cases, malignant tumors arise from ovarian mature cystic teratoma. A variety of tumors can arise from mature cystic teratoma, among which primary malignant melanoma (MM), for which no molecular analyses such as genomic sequencing have been reported to date, is exceedingly rare, thereby limiting possible therapeutic options using precision medicine. We used targeted gene sequencing to analyze the status of 160 cancer-related genes in a patient with MM arising from an ovarian mature cystic teratoma (MM-MCT). KRAS amplification and homozygous deletion in PTEN and RB1 were detected in tumor samples collected from the patient. No KRAS amplification has been previously reported in cutaneous MM, indicating that the carcinogenesis of MM-MCT differs from that of primary cutaneous melanomas. A better understanding of the underlying genetic mechanisms will help clarify the carcinogenesis of MM-MCT. In turn, this will enable treatment with novel targeting agents as well as the initial exploration of gene-based precision oncological therapies, which aim to improve treatment outcomes for patients with this disease.

Mature Cystic Teratoma of the Greater Omentum

1990 ◽  
Vol 10 (6) ◽  
pp. 1033-1035 ◽  
Author(s):  
Ricardo Drut ◽  
Rosa Mónica Drut ◽  
Francisco Vollaro
Keyword(s):  
Cystic Teratoma ◽  
Mature Cystic Teratoma ◽  
Greater Omentum

Fibrin‐associated diffuse large B‐cell lymphoma arising in a mature cystic teratoma: A case report

2019 ◽  
Vol 69 (5) ◽  
pp. 312-314 ◽  
Author(s):  
Kenji Yorita ◽  
Yu Tanaka ◽  
Koki Hirano ◽  
Miki Mizobuchi ◽  
Kei Kohno ◽  
...  
Keyword(s):  
Case Report ◽  
B Cell ◽  
Cell Lymphoma ◽  
Cystic Teratoma ◽  
B Cell Lymphoma ◽  
Mature Cystic Teratoma ◽  
Large B Cell Lymphoma ◽  
Large B Cell

Laminated saccules: a residuum of an ovarian mature cystic teratoma

Pathology ◽  
2015 ◽  
Vol 47 (7) ◽  
pp. 710-711
Author(s):  
Aadil Rahim ◽  
Ran May Saw ◽  
John Bailey ◽  
James Scurry
Keyword(s):  
Cystic Teratoma ◽  
Mature Cystic Teratoma

Squamous cell carcinoma arising in an ovarian mature cystic teratoma complicating pregnancy: a case report

2008 ◽  
Vol 278 (3) ◽  
pp. 287-290 ◽  
Author(s):  
Keiko Mekaru ◽  
Shigeru Kamiyama ◽  
Hitoshi Masamoto ◽  
Chiaki Yagi ◽  
Makoto Hirakawa ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Case Report ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Cystic Teratoma ◽  
Mature Cystic Teratoma
Sign in / Sign up

Export Citation Format

Share Document